

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of dendrite morphogenesis (GO:0050774) | 8.37696037 |
| 2 | regulation of cardioblast proliferation (GO:0003264) | 8.00853974 |
| 3 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 8.00853974 |
| 4 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 7.48989420 |
| 5 | synaptic transmission, cholinergic (GO:0007271) | 7.11080609 |
| 6 | coronary vasculature morphogenesis (GO:0060977) | 7.07077153 |
| 7 | neurotransmitter catabolic process (GO:0042135) | 6.82784293 |
| 8 | endocardial cushion morphogenesis (GO:0003203) | 6.32967601 |
| 9 | norepinephrine metabolic process (GO:0042415) | 6.26859613 |
| 10 | catecholamine biosynthetic process (GO:0042423) | 6.21783420 |
| 11 | catechol-containing compound biosynthetic process (GO:0009713) | 6.21783420 |
| 12 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 5.96079929 |
| 13 | behavioral response to ethanol (GO:0048149) | 5.92502528 |
| 14 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 5.84714205 |
| 15 | dopamine metabolic process (GO:0042417) | 5.77695620 |
| 16 | cell migration involved in heart development (GO:0060973) | 5.47850157 |
| 17 | neurotransmitter biosynthetic process (GO:0042136) | 5.25147754 |
| 18 | cardiac ventricle formation (GO:0003211) | 5.03652871 |
| 19 | mesenchyme morphogenesis (GO:0072132) | 4.99119707 |
| 20 | negative regulation of microtubule polymerization (GO:0031115) | 4.97745323 |
| 21 | dopamine biosynthetic process (GO:0042416) | 4.97279608 |
| 22 | cardiac chamber formation (GO:0003207) | 4.95701420 |
| 23 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 4.88188600 |
| 24 | catecholamine transport (GO:0051937) | 4.80428724 |
| 25 | neuromuscular synaptic transmission (GO:0007274) | 4.79438732 |
| 26 | negative regulation of dendrite development (GO:2000171) | 4.75055008 |
| 27 | cellular response to prostaglandin stimulus (GO:0071379) | 4.74489042 |
| 28 | response to parathyroid hormone (GO:0071107) | 4.74332720 |
| 29 | body morphogenesis (GO:0010171) | 4.74210931 |
| 30 | neurofilament cytoskeleton organization (GO:0060052) | 4.63265565 |
| 31 | tongue development (GO:0043586) | 4.57053720 |
| 32 | * dopaminergic neuron differentiation (GO:0071542) | 4.51488560 |
| 33 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.51156383 |
| 34 | alkaloid metabolic process (GO:0009820) | 4.48922754 |
| 35 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.47104543 |
| 36 | catecholamine metabolic process (GO:0006584) | 4.41396043 |
| 37 | catechol-containing compound metabolic process (GO:0009712) | 4.41396043 |
| 38 | response to water (GO:0009415) | 4.41006641 |
| 39 | regulation of striated muscle cell apoptotic process (GO:0010662) | 4.39033670 |
| 40 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 4.33338753 |
| 41 | cartilage morphogenesis (GO:0060536) | 4.32430482 |
| 42 | maternal behavior (GO:0042711) | 4.27976198 |
| 43 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.21328060 |
| 44 | arginine catabolic process (GO:0006527) | 4.11865053 |
| 45 | peripheral nervous system neuron development (GO:0048935) | 4.10153718 |
| 46 | axon extension involved in axon guidance (GO:0048846) | 4.09002326 |
| 47 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 4.09002326 |
| 48 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.03919375 |
| 49 | * enteric nervous system development (GO:0048484) | 4.00599116 |
| 50 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 4.00544166 |
| 51 | response to pain (GO:0048265) | 3.91345820 |
| 52 | suckling behavior (GO:0001967) | 3.90683473 |
| 53 | mating behavior (GO:0007617) | 3.88140271 |
| 54 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.80632820 |
| 55 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.80632820 |
| 56 | mesenchymal cell proliferation (GO:0010463) | 3.79159323 |
| 57 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.76596428 |
| 58 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.73357583 |
| 59 | exogenous drug catabolic process (GO:0042738) | 3.72601751 |
| 60 | response to amphetamine (GO:0001975) | 3.68416251 |
| 61 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.66311967 |
| 62 | cellular response to nicotine (GO:0071316) | 3.64467512 |
| 63 | parental behavior (GO:0060746) | 3.63296672 |
| 64 | neurotransmitter metabolic process (GO:0042133) | 3.57297440 |
| 65 | proline transport (GO:0015824) | 3.55614825 |
| 66 | phenol-containing compound biosynthetic process (GO:0046189) | 3.54507144 |
| 67 | response to prostaglandin E (GO:0034695) | 3.49577346 |
| 68 | * regulation of respiratory gaseous exchange (GO:0043576) | 3.44806347 |
| 69 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.44745124 |
| 70 | positive regulation of response to oxidative stress (GO:1902884) | 3.44745124 |
| 71 | negative regulation of DNA repair (GO:0045738) | 3.42306655 |
| 72 | auditory receptor cell stereocilium organization (GO:0060088) | 3.40295073 |
| 73 | adult heart development (GO:0007512) | 3.34105736 |
| 74 | nucleobase catabolic process (GO:0046113) | 3.28964732 |
| 75 | regulation of dendrite morphogenesis (GO:0048814) | 3.28356155 |
| 76 | embryonic body morphogenesis (GO:0010172) | 3.27956832 |
| 77 | ectodermal placode formation (GO:0060788) | 3.27440347 |
| 78 | skeletal muscle organ development (GO:0060538) | 3.25012901 |
| 79 | regulation of transcription regulatory region DNA binding (GO:2000677) | 3.24092156 |
| 80 | toxin metabolic process (GO:0009404) | 3.23157686 |
| 81 | primary amino compound metabolic process (GO:1901160) | 3.22963465 |
| 82 | response to nerve growth factor (GO:1990089) | 3.20573437 |
| 83 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.20573437 |
| 84 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.18945926 |
| 85 | spinal cord motor neuron differentiation (GO:0021522) | 3.18589828 |
| 86 | regulation of neurotransmitter transport (GO:0051588) | 3.14552983 |
| 87 | response to nicotine (GO:0035094) | 3.11025281 |
| 88 | negative regulation of muscle cell apoptotic process (GO:0010656) | 3.10733606 |
| 89 | neuron cell-cell adhesion (GO:0007158) | 3.10249220 |
| 90 | innervation (GO:0060384) | 3.09625145 |
| 91 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.09289416 |
| 92 | relaxation of smooth muscle (GO:0044557) | 3.04765992 |
| 93 | * neural crest cell migration (GO:0001755) | 3.04155994 |
| 94 | regulation of cell maturation (GO:1903429) | 3.04132362 |
| 95 | oxygen transport (GO:0015671) | 3.04100087 |
| 96 | neural crest cell development (GO:0014032) | 3.03983147 |
| 97 | regulation of heart morphogenesis (GO:2000826) | 3.03778178 |
| 98 | regulation of neurotransmitter uptake (GO:0051580) | 3.03299505 |
| 99 | peristalsis (GO:0030432) | 3.02123819 |
| 100 | apoptotic process involved in development (GO:1902742) | 2.99733183 |
| 101 | negative regulation of multicellular organism growth (GO:0040015) | 2.96612679 |
| 102 | dopamine receptor signaling pathway (GO:0007212) | 2.93930969 |
| 103 | outflow tract septum morphogenesis (GO:0003148) | 2.93813197 |
| 104 | positive regulation of protein depolymerization (GO:1901881) | 2.93488280 |
| 105 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.93107869 |
| 106 | layer formation in cerebral cortex (GO:0021819) | 2.91506949 |
| 107 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.90259423 |
| 108 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.89007955 |
| 109 | heart morphogenesis (GO:0003007) | 2.88566277 |
| 110 | auditory behavior (GO:0031223) | 2.88452217 |
| 111 | regulation of mRNA catabolic process (GO:0061013) | 2.88427977 |
| 112 | neurotransmitter secretion (GO:0007269) | 2.88087901 |
| 113 | regulation of neurotransmitter secretion (GO:0046928) | 2.87305278 |
| 114 | positive regulation of neurotransmitter transport (GO:0051590) | 2.87244060 |
| 115 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.87121077 |
| 116 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.87121077 |
| 117 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.86981816 |
| 118 | positive regulation of DNA binding (GO:0043388) | 2.85430298 |
| 119 | negative regulation of mRNA metabolic process (GO:1903312) | 2.85113084 |
| 120 | adrenergic receptor signaling pathway (GO:0071875) | 2.83984095 |
| 121 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.83268383 |
| 122 | drug catabolic process (GO:0042737) | 2.81705810 |
| 123 | positive regulation of RNA splicing (GO:0033120) | 2.79851018 |
| 124 | detection of temperature stimulus (GO:0016048) | 2.79332999 |
| 125 | midbrain development (GO:0030901) | 2.79124528 |
| 126 | stress granule assembly (GO:0034063) | 2.78854581 |
| 127 | negative regulation of neurotransmitter transport (GO:0051589) | 2.78531394 |
| 128 | * cell migration in hindbrain (GO:0021535) | 2.78141636 |
| 129 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.76648558 |
| 130 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.76648558 |
| 131 | apoptotic process involved in morphogenesis (GO:0060561) | 2.76108553 |
| 132 | viral transcription (GO:0019083) | 2.75971809 |
| 133 | positive regulation of cell size (GO:0045793) | 2.73838119 |
| 134 | locomotory exploration behavior (GO:0035641) | 2.70223113 |
| 135 | cranial nerve development (GO:0021545) | 2.70158791 |
| 136 | nuclear pore complex assembly (GO:0051292) | 2.64917831 |
| 137 | spliceosomal complex assembly (GO:0000245) | 2.60528966 |
| 138 | cell differentiation in spinal cord (GO:0021515) | 2.60424529 |
| 139 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.59976633 |
| 140 | embryonic digit morphogenesis (GO:0042733) | 2.57822370 |
| 141 | negative chemotaxis (GO:0050919) | 2.57143086 |
| 142 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.55219005 |
| 143 | cranial nerve morphogenesis (GO:0021602) | 2.53016589 |
| 144 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.49507268 |
| 145 | protein-DNA complex disassembly (GO:0032986) | 2.48636594 |
| 146 | nucleosome disassembly (GO:0006337) | 2.48636594 |
| 147 | mesenchymal cell development (GO:0014031) | 2.48216312 |
| 148 | positive regulation of glomerulus development (GO:0090193) | 2.46441312 |
| 149 | outer ear morphogenesis (GO:0042473) | 2.44601054 |
| 150 | phenol-containing compound catabolic process (GO:0019336) | 13.0828879 |
| 151 | * sympathetic nervous system development (GO:0048485) | 11.3488584 |
| 152 | behavioral response to nicotine (GO:0035095) | 11.2573199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.40723301 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.14400483 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.89509137 |
| 4 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 3.76488633 |
| 5 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.13556493 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.01460791 |
| 7 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 3.00004528 |
| 8 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.96987122 |
| 9 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.95715690 |
| 10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.93522314 |
| 11 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.93522314 |
| 12 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.92381461 |
| 13 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.92199512 |
| 14 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.75956158 |
| 15 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.69826451 |
| 16 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.64030106 |
| 17 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.59217013 |
| 18 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.58041288 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.51424858 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.51294937 |
| 21 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.38519691 |
| 22 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.36483565 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.35745433 |
| 24 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.33128234 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.24926050 |
| 26 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.24810551 |
| 27 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17365830 |
| 28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.17018764 |
| 29 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.13954437 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.11468335 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.07651275 |
| 32 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.07045016 |
| 33 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.04614244 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.03204759 |
| 35 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.03140187 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.02300274 |
| 37 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95720274 |
| 38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.93250801 |
| 39 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.88768810 |
| 40 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.83404611 |
| 41 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.80092153 |
| 42 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.77374308 |
| 43 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.72538330 |
| 44 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.65319967 |
| 45 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.62804435 |
| 46 | KDM2B_26808549_Chip-Seq_K562_Human | 1.60062193 |
| 47 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.59337756 |
| 48 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.56504736 |
| 49 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.53865196 |
| 50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.42736629 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40967367 |
| 52 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.40558974 |
| 53 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.39657749 |
| 54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.35245718 |
| 55 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.32394618 |
| 56 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.31917142 |
| 57 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.31205162 |
| 58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30428307 |
| 59 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30170245 |
| 60 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.29115786 |
| 61 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.24828221 |
| 62 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.23536563 |
| 63 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.23484388 |
| 64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.23240240 |
| 65 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22645736 |
| 66 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.20792290 |
| 67 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.20701910 |
| 68 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.18956094 |
| 69 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.18904492 |
| 70 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.18678856 |
| 71 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.17896645 |
| 72 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16617496 |
| 73 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.16092408 |
| 74 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.15908546 |
| 75 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.15578112 |
| 76 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.15042592 |
| 77 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.14206287 |
| 78 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12456821 |
| 79 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12119780 |
| 80 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.10813911 |
| 81 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10687608 |
| 82 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.10533008 |
| 83 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09956524 |
| 84 | JUN_21703547_ChIP-Seq_K562_Human | 1.09274212 |
| 85 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.08036451 |
| 86 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08015498 |
| 87 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.06698095 |
| 88 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.06363970 |
| 89 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.06151144 |
| 90 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.03013810 |
| 91 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.01505892 |
| 92 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.01015125 |
| 93 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99790894 |
| 94 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99068193 |
| 95 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.98560362 |
| 96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.97613947 |
| 97 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.97489546 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.96722657 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96023872 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95685578 |
| 101 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.95469184 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95083192 |
| 103 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94108813 |
| 104 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.93139080 |
| 105 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.92938395 |
| 106 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.92899243 |
| 107 | POU3F1_26484290_ChIP-Seq_ESCss_Mouse | 0.91867975 |
| 108 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.91386351 |
| 109 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.91351043 |
| 110 | P300_19829295_ChIP-Seq_ESCs_Human | 0.90429515 |
| 111 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90391535 |
| 112 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.88645401 |
| 113 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.88041003 |
| 114 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87726349 |
| 115 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.87667807 |
| 116 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.87064546 |
| 117 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87017129 |
| 118 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.86636017 |
| 119 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86243470 |
| 120 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86157081 |
| 121 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.85989637 |
| 122 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.85050956 |
| 123 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.84644398 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83315344 |
| 125 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.82812451 |
| 126 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.81688841 |
| 127 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.81272587 |
| 128 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.81010162 |
| 129 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.79592904 |
| 130 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78889663 |
| 131 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.78759276 |
| 132 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.78551343 |
| 133 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.77965635 |
| 134 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.77350397 |
| 135 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.77202930 |
| 136 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76970258 |
| 137 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.76320176 |
| 138 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.75705163 |
| 139 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.75700707 |
| 140 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74042985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 8.82682515 |
| 2 | MP0010386_abnormal_urinary_bladder | 5.42076124 |
| 3 | MP0002751_abnormal_autonomic_nervous | 4.39440365 |
| 4 | MP0002009_preneoplasia | 3.50584787 |
| 5 | MP0002653_abnormal_ependyma_morphology | 3.47148364 |
| 6 | MP0000538_abnormal_urinary_bladder | 3.44162627 |
| 7 | MP0003123_paternal_imprinting | 3.39944833 |
| 8 | MP0003787_abnormal_imprinting | 3.33933050 |
| 9 | MP0003122_maternal_imprinting | 3.18303316 |
| 10 | * MP0002638_abnormal_pupillary_reflex | 3.08522431 |
| 11 | MP0004858_abnormal_nervous_system | 3.03074855 |
| 12 | MP0005645_abnormal_hypothalamus_physiol | 2.58935927 |
| 13 | MP0001905_abnormal_dopamine_level | 2.41248707 |
| 14 | MP0004270_analgesia | 2.38997236 |
| 15 | MP0001529_abnormal_vocalization | 2.24717260 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.16226993 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.05167736 |
| 18 | MP0009745_abnormal_behavioral_response | 1.99646069 |
| 19 | MP0008877_abnormal_DNA_methylation | 1.98670367 |
| 20 | MP0003567_abnormal_fetal_cardiomyocyte | 1.88028917 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 1.85759580 |
| 22 | MP0003942_abnormal_urinary_system | 1.80055787 |
| 23 | MP0008961_abnormal_basal_metabolism | 1.76435372 |
| 24 | MP0008872_abnormal_physiological_respon | 1.72723255 |
| 25 | MP0002909_abnormal_adrenal_gland | 1.72248914 |
| 26 | MP0000049_abnormal_middle_ear | 1.69047647 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.64116531 |
| 28 | MP0001970_abnormal_pain_threshold | 1.62343761 |
| 29 | MP0001501_abnormal_sleep_pattern | 1.62282803 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.57188078 |
| 31 | MP0003635_abnormal_synaptic_transmissio | 1.53904124 |
| 32 | MP0002184_abnormal_innervation | 1.53785648 |
| 33 | MP0000778_abnormal_nervous_system | 1.42850061 |
| 34 | * MP0005197_abnormal_uvea_morphology | 1.33783064 |
| 35 | MP0006138_congestive_heart_failure | 1.33691476 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 1.33267315 |
| 37 | MP0009379_abnormal_foot_pigmentation | 1.33149240 |
| 38 | MP0003121_genomic_imprinting | 1.32362074 |
| 39 | MP0004142_abnormal_muscle_tone | 1.28294380 |
| 40 | MP0005408_hypopigmentation | 1.27417087 |
| 41 | MP0004924_abnormal_behavior | 1.24341781 |
| 42 | MP0005386_behavior/neurological_phenoty | 1.24341781 |
| 43 | MP0002064_seizures | 1.14990378 |
| 44 | MP0001270_distended_abdomen | 1.14985682 |
| 45 | MP0001756_abnormal_urination | 1.13318273 |
| 46 | MP0002063_abnormal_learning/memory/cond | 1.10966077 |
| 47 | MP0005623_abnormal_meninges_morphology | 1.06160634 |
| 48 | * MP0000955_abnormal_spinal_cord | 1.05390095 |
| 49 | MP0000534_abnormal_ureter_morphology | 1.02747772 |
| 50 | MP0004233_abnormal_muscle_weight | 1.02351578 |
| 51 | MP0006072_abnormal_retinal_apoptosis | 1.02320337 |
| 52 | MP0004859_abnormal_synaptic_plasticity | 1.01450036 |
| 53 | MP0005409_darkened_coat_color | 1.01338680 |
| 54 | MP0003115_abnormal_respiratory_system | 1.00002570 |
| 55 | MP0002272_abnormal_nervous_system | 0.99655645 |
| 56 | MP0000372_irregular_coat_pigmentation | 0.99440982 |
| 57 | MP0003646_muscle_fatigue | 0.99279616 |
| 58 | MP0003077_abnormal_cell_cycle | 0.98884609 |
| 59 | MP0000762_abnormal_tongue_morphology | 0.98048934 |
| 60 | MP0003935_abnormal_craniofacial_develop | 0.97660789 |
| 61 | MP0000003_abnormal_adipose_tissue | 0.94883297 |
| 62 | MP0000427_abnormal_hair_cycle | 0.92729993 |
| 63 | MP0001299_abnormal_eye_distance/ | 0.92622339 |
| 64 | MP0000751_myopathy | 0.91861009 |
| 65 | MP0005253_abnormal_eye_physiology | 0.91354467 |
| 66 | MP0003937_abnormal_limbs/digits/tail_de | 0.90153185 |
| 67 | MP0002557_abnormal_social/conspecific_i | 0.89431598 |
| 68 | MP0008932_abnormal_embryonic_tissue | 0.88938488 |
| 69 | MP0008569_lethality_at_weaning | 0.86513963 |
| 70 | MP0005423_abnormal_somatic_nervous | 0.84958993 |
| 71 | MP0000477_abnormal_intestine_morphology | 0.84496139 |
| 72 | MP0001984_abnormal_olfaction | 0.83312998 |
| 73 | * MP0002081_perinatal_lethality | 0.83169634 |
| 74 | MP0002163_abnormal_gland_morphology | 0.82867947 |
| 75 | * MP0004811_abnormal_neuron_physiology | 0.82187380 |
| 76 | MP0009250_abnormal_appendicular_skeleto | 0.81818531 |
| 77 | * MP0002152_abnormal_brain_morphology | 0.81664357 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 0.79657077 |
| 79 | MP0004883_abnormal_blood_vessel | 0.79420963 |
| 80 | * MP0002127_abnormal_cardiovascular_syste | 0.79169418 |
| 81 | * MP0002882_abnormal_neuron_morphology | 0.78914225 |
| 82 | MP0003638_abnormal_response/metabolism_ | 0.78670654 |
| 83 | MP0005076_abnormal_cell_differentiation | 0.78344362 |
| 84 | MP0008770_decreased_survivor_rate | 0.77695449 |
| 85 | MP0002069_abnormal_eating/drinking_beha | 0.77628847 |
| 86 | MP0004085_abnormal_heartbeat | 0.77171023 |
| 87 | MP0002085_abnormal_embryonic_tissue | 0.76962694 |
| 88 | MP0010094_abnormal_chromosome_stability | 0.76051718 |
| 89 | * MP0002752_abnormal_somatic_nervous | 0.75817713 |
| 90 | MP0003868_abnormal_feces_composition | 0.75232803 |
| 91 | MP0002932_abnormal_joint_morphology | 0.75101732 |
| 92 | MP0003329_amyloid_beta_deposits | 0.73805032 |
| 93 | MP0000759_abnormal_skeletal_muscle | 0.72784325 |
| 94 | MP0005083_abnormal_biliary_tract | 0.72444359 |
| 95 | MP0002109_abnormal_limb_morphology | 0.72404825 |
| 96 | MP0003279_aneurysm | 0.72302804 |
| 97 | MP0003959_abnormal_lean_body | 0.71805203 |
| 98 | MP0005503_abnormal_tendon_morphology | 0.71547025 |
| 99 | MP0001346_abnormal_lacrimal_gland | 0.71201608 |
| 100 | MP0002066_abnormal_motor_capabilities/c | 0.70660234 |
| 101 | MP0009672_abnormal_birth_weight | 0.70638171 |
| 102 | MP0000639_abnormal_adrenal_gland | 0.70335519 |
| 103 | MP0004130_abnormal_muscle_cell | 0.70332638 |
| 104 | MP0000681_abnormal_thyroid_gland | 0.70265311 |
| 105 | MP0003111_abnormal_nucleus_morphology | 0.70233658 |
| 106 | MP0005187_abnormal_penis_morphology | 0.70233234 |
| 107 | MP0002114_abnormal_axial_skeleton | 0.70002446 |
| 108 | * MP0001943_abnormal_respiration | 0.68598726 |
| 109 | MP0001664_abnormal_digestion | 0.68477367 |
| 110 | MP0003315_abnormal_perineum_morphology | 0.68439419 |
| 111 | * MP0003948_abnormal_gas_homeostasis | 0.67949435 |
| 112 | MP0003633_abnormal_nervous_system | 0.67808954 |
| 113 | MP0002084_abnormal_developmental_patter | 0.67643108 |
| 114 | MP0008874_decreased_physiological_sensi | 0.67550230 |
| 115 | MP0006292_abnormal_olfactory_placode | 0.66855251 |
| 116 | MP0009046_muscle_twitch | 0.66742762 |
| 117 | MP0002249_abnormal_larynx_morphology | 0.65672062 |
| 118 | MP0003705_abnormal_hypodermis_morpholog | 0.65623228 |
| 119 | MP0002067_abnormal_sensory_capabilities | 0.65102495 |
| 120 | MP0003861_abnormal_nervous_system | 0.63312554 |
| 121 | MP0001340_abnormal_eyelid_morphology | 0.62643403 |
| 122 | MP0008057_abnormal_DNA_replication | 0.62213901 |
| 123 | MP0002735_abnormal_chemical_nociception | 0.60841766 |
| 124 | * MP0003631_nervous_system_phenotype | 0.60506779 |
| 125 | MP0001730_embryonic_growth_arrest | 0.59908159 |
| 126 | MP0000537_abnormal_urethra_morphology | 0.58174297 |
| 127 | * MP0010770_preweaning_lethality | 0.57682554 |
| 128 | * MP0002082_postnatal_lethality | 0.57682554 |
| 129 | MP0001348_abnormal_lacrimal_gland | 0.57084292 |
| 130 | MP0001188_hyperpigmentation | 0.56275391 |
| 131 | MP0002116_abnormal_craniofacial_bone | 0.56060324 |
| 132 | * MP0010769_abnormal_survival | 0.55913157 |
| 133 | MP0009703_decreased_birth_body | 0.55666893 |
| 134 | MP0003045_fibrosis | 0.54637870 |
| 135 | MP0003755_abnormal_palate_morphology | 0.54137334 |
| 136 | MP0002697_abnormal_eye_size | 0.54056510 |
| 137 | * MP0010768_mortality/aging | 0.53943627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asymmetry of the thorax (HP:0001555) | 8.57686980 |
| 2 | Orthostatic hypotension (HP:0001278) | 7.70922093 |
| 3 | Hyperthyroidism (HP:0000836) | 6.20297193 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.13616422 |
| 5 | Neonatal hypoglycemia (HP:0001998) | 6.11931932 |
| 6 | Amblyopia (HP:0000646) | 6.07658878 |
| 7 | Abnormal autonomic nervous system physiology (HP:0012332) | 5.57493682 |
| 8 | Enlarged penis (HP:0000040) | 5.52225043 |
| 9 | Exotropia (HP:0000577) | 5.39603956 |
| 10 | Myokymia (HP:0002411) | 5.10066463 |
| 11 | Agitation (HP:0000713) | 5.06215976 |
| 12 | Menstrual irregularities (HP:0000858) | 4.96573712 |
| 13 | Hypercortisolism (HP:0001578) | 4.92231847 |
| 14 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 4.86769833 |
| 15 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.56858559 |
| 16 | Esophageal atresia (HP:0002032) | 4.37194856 |
| 17 | Abnormality of the corticospinal tract (HP:0002492) | 4.26611012 |
| 18 | Growth hormone excess (HP:0000845) | 4.17195560 |
| 19 | Pheochromocytoma (HP:0002666) | 3.94672862 |
| 20 | Intestinal atresia (HP:0011100) | 3.91327265 |
| 21 | Abnormality of the phalanges of the hallux (HP:0010057) | 3.89689727 |
| 22 | Limb dystonia (HP:0002451) | 3.85580808 |
| 23 | Shawl scrotum (HP:0000049) | 3.85578318 |
| 24 | Hyperparathyroidism (HP:0000843) | 3.83045656 |
| 25 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.80316752 |
| 26 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.80316752 |
| 27 | Breast hypoplasia (HP:0003187) | 3.79804586 |
| 28 | Impulsivity (HP:0100710) | 3.55409044 |
| 29 | Testicular neoplasm (HP:0010788) | 3.52237617 |
| 30 | Hypotension (HP:0002615) | 3.49442717 |
| 31 | External ophthalmoplegia (HP:0000544) | 3.49023254 |
| 32 | Restlessness (HP:0000711) | 3.43650280 |
| 33 | Neuroendocrine neoplasm (HP:0100634) | 3.43010521 |
| 34 | Abnormality of the 2nd finger (HP:0004100) | 3.23340306 |
| 35 | Annular pancreas (HP:0001734) | 3.19727044 |
| 36 | Hypoplastic nipples (HP:0002557) | 3.17631356 |
| 37 | Midline defect of the nose (HP:0004122) | 3.14160994 |
| 38 | Malnutrition (HP:0004395) | 3.12997584 |
| 39 | Macroorchidism (HP:0000053) | 3.10342322 |
| 40 | Goiter (HP:0000853) | 2.96324384 |
| 41 | Depressed nasal tip (HP:0000437) | 2.91102569 |
| 42 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.83895279 |
| 43 | Abnormality of the vocal cords (HP:0008777) | 2.78148505 |
| 44 | Partial duplication of the phalanx of hand (HP:0009999) | 2.74559321 |
| 45 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.74530542 |
| 46 | Bowel diverticulosis (HP:0005222) | 2.71007401 |
| 47 | Thyroid carcinoma (HP:0002890) | 2.70580021 |
| 48 | Gastrointestinal atresia (HP:0002589) | 2.68654136 |
| 49 | Potter facies (HP:0002009) | 2.68577638 |
| 50 | Facial shape deformation (HP:0011334) | 2.68577638 |
| 51 | Myotonia (HP:0002486) | 2.67470849 |
| 52 | Striae distensae (HP:0001065) | 2.66822523 |
| 53 | Palpebral edema (HP:0100540) | 2.66153088 |
| 54 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.63259562 |
| 55 | Tubulointerstitial fibrosis (HP:0005576) | 2.61645865 |
| 56 | Patellar aplasia (HP:0006443) | 2.58661183 |
| 57 | Abnormality of the parietal bone (HP:0002696) | 2.58289045 |
| 58 | Adrenal overactivity (HP:0002717) | 2.56798618 |
| 59 | Hyperphosphatemia (HP:0002905) | 2.56296680 |
| 60 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.55539609 |
| 61 | Failure to thrive in infancy (HP:0001531) | 2.54205744 |
| 62 | Neoplasm of the thyroid gland (HP:0100031) | 2.53053508 |
| 63 | Long toe (HP:0010511) | 2.51407680 |
| 64 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.49645913 |
| 65 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.49627799 |
| 66 | Abnormality of the 4th metacarpal (HP:0010012) | 2.48289208 |
| 67 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.48111428 |
| 68 | Short 4th metacarpal (HP:0010044) | 2.48111428 |
| 69 | Turricephaly (HP:0000262) | 2.46336359 |
| 70 | Action tremor (HP:0002345) | 2.42770302 |
| 71 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.42734950 |
| 72 | Generalized hypotonia (HP:0001290) | 2.42521384 |
| 73 | Abnormality of the parathyroid morphology (HP:0011766) | 2.36782562 |
| 74 | Neonatal onset (HP:0003623) | 2.34772541 |
| 75 | Intestinal polyposis (HP:0200008) | 2.33450385 |
| 76 | High anterior hairline (HP:0009890) | 2.33415744 |
| 77 | Sandal gap (HP:0001852) | 2.32269197 |
| 78 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.31381228 |
| 79 | Hypotrichosis (HP:0001006) | 2.30252943 |
| 80 | Partial agenesis of the corpus callosum (HP:0001338) | 2.26597273 |
| 81 | Type 2 muscle fiber atrophy (HP:0003554) | 2.26529903 |
| 82 | Sacral dimple (HP:0000960) | 2.26044020 |
| 83 | Episodic fever (HP:0001954) | 2.22667490 |
| 84 | Cranial hyperostosis (HP:0004437) | 2.22041356 |
| 85 | Cerebral hemorrhage (HP:0001342) | 2.20813622 |
| 86 | Hyperacusis (HP:0010780) | 2.17416797 |
| 87 | Arthropathy (HP:0003040) | 2.17302103 |
| 88 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.15663013 |
| 89 | Tubulointerstitial abnormality (HP:0001969) | 2.14245175 |
| 90 | * Hypoventilation (HP:0002791) | 2.13500605 |
| 91 | Supernumerary spleens (HP:0009799) | 2.12602890 |
| 92 | Intestinal polyp (HP:0005266) | 2.11286866 |
| 93 | Wide anterior fontanel (HP:0000260) | 2.10387402 |
| 94 | Abnormality of pain sensation (HP:0010832) | 2.09096316 |
| 95 | Impaired pain sensation (HP:0007328) | 2.09096316 |
| 96 | Depression (HP:0000716) | 2.07402632 |
| 97 | Anxiety (HP:0000739) | 2.07258174 |
| 98 | Delayed cranial suture closure (HP:0000270) | 2.05938400 |
| 99 | Sex reversal (HP:0012245) | 2.05854144 |
| 100 | Abnormal sex determination (HP:0012244) | 2.05854144 |
| 101 | Postural tremor (HP:0002174) | 2.05612758 |
| 102 | Pseudobulbar signs (HP:0002200) | 2.01530629 |
| 103 | Poor suck (HP:0002033) | 2.01258943 |
| 104 | Hypothermia (HP:0002045) | 11.3127929 |
| 105 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.98970125 |
| 106 | Facial asymmetry (HP:0000324) | 1.98093857 |
| 107 | Abnormal hemoglobin (HP:0011902) | 1.96123501 |
| 108 | Cortical dysplasia (HP:0002539) | 1.95778248 |
| 109 | Focal seizures (HP:0007359) | 1.95298821 |
| 110 | Degeneration of anterior horn cells (HP:0002398) | 1.95158032 |
| 111 | Abnormality of the anterior horn cell (HP:0006802) | 1.95158032 |
| 112 | Muscle fiber atrophy (HP:0100295) | 1.94425713 |
| 113 | Abnormality of the aortic arch (HP:0012303) | 1.91863154 |
| 114 | Aplasia/Hypoplasia of the nipples (HP:0006709) | 1.91527192 |
| 115 | Hypoparathyroidism (HP:0000829) | 1.91026214 |
| 116 | Renovascular hypertension (HP:0100817) | 1.90305138 |
| 117 | Autoamputation (HP:0001218) | 1.90298012 |
| 118 | Precocious puberty (HP:0000826) | 1.88797042 |
| 119 | Ulnar claw (HP:0001178) | 1.88053663 |
| 120 | Buphthalmos (HP:0000557) | 1.84941975 |
| 121 | Aqueductal stenosis (HP:0002410) | 1.82047159 |
| 122 | Thick eyebrow (HP:0000574) | 1.81192570 |
| 123 | Rhinitis (HP:0012384) | 1.80963238 |
| 124 | Stenosis of the external auditory canal (HP:0000402) | 1.80779001 |
| 125 | Long nose (HP:0003189) | 1.80125390 |
| 126 | Neoplasm of the heart (HP:0100544) | 1.79680972 |
| 127 | Renal dysplasia (HP:0000110) | 1.76954966 |
| 128 | Short palpebral fissure (HP:0012745) | 1.75865037 |
| 129 | Ectopic kidney (HP:0000086) | 1.73898832 |
| 130 | Delusions (HP:0000746) | 1.73777924 |
| 131 | Bicornuate uterus (HP:0000813) | 1.72231848 |
| 132 | Increased corneal curvature (HP:0100692) | 1.71249221 |
| 133 | Keratoconus (HP:0000563) | 1.71249221 |
| 134 | Absent radius (HP:0003974) | 1.70344403 |
| 135 | Cutaneous finger syndactyly (HP:0010554) | 1.69236136 |
| 136 | Secondary amenorrhea (HP:0000869) | 1.67642759 |
| 137 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.67603332 |
| 138 | Elfin facies (HP:0004428) | 1.67548814 |
| 139 | Abnormal gallbladder physiology (HP:0012438) | 1.67351651 |
| 140 | Cholecystitis (HP:0001082) | 1.67351651 |
| 141 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.65624426 |
| 142 | Hammertoe (HP:0001765) | 1.65534124 |
| 143 | Limb hypertonia (HP:0002509) | 1.65114745 |
| 144 | Obsessive-compulsive behavior (HP:0000722) | 1.64598863 |
| 145 | Sensory axonal neuropathy (HP:0003390) | 1.64270863 |
| 146 | Hypoproteinemia (HP:0003075) | 1.63397863 |
| 147 | Single transverse palmar crease (HP:0000954) | 1.63339930 |
| 148 | Chromsome breakage (HP:0040012) | 1.62913664 |
| 149 | Self-mutilation (HP:0000742) | 1.62844776 |
| 150 | Brachycephaly (HP:0000248) | 1.62150567 |
| 151 | Spina bifida occulta (HP:0003298) | 1.60689085 |
| 152 | Round face (HP:0000311) | 1.60299528 |
| 153 | Short metatarsal (HP:0010743) | 1.57895451 |
| 154 | Sleep apnea (HP:0010535) | 1.55494293 |
| 155 | Thickened calvaria (HP:0002684) | 1.55332226 |
| 156 | Psychosis (HP:0000709) | 1.53743144 |
| 157 | Pathologic fracture (HP:0002756) | 1.51509089 |
| 158 | Wrist flexion contracture (HP:0001239) | 1.51420221 |
| 159 | Morphological abnormality of the middle ear (HP:0008609) | 1.51277925 |
| 160 | Hyperpituitarism (HP:0010514) | 1.50999157 |
| 161 | Supranuclear gaze palsy (HP:0000605) | 1.49901731 |
| 162 | Recurrent corneal erosions (HP:0000495) | 1.49802411 |
| 163 | Osteopenia (HP:0000938) | 1.48084322 |
| 164 | Generalized tonic-clonic seizures (HP:0002069) | 1.44373791 |
| 165 | Abnormality of the pulmonary veins (HP:0011718) | 1.43138456 |
| 166 | Torticollis (HP:0000473) | 1.43062378 |
| 167 | Craniofacial dystonia (HP:0012179) | 1.42847797 |
| 168 | Emotional lability (HP:0000712) | 1.42711427 |
| 169 | Truncus arteriosus (HP:0001660) | 1.42010127 |
| 170 | Atonic seizures (HP:0010819) | 1.41244169 |
| 171 | Abnormal pupillary function (HP:0007686) | 1.41160785 |
| 172 | Adducted thumb (HP:0001181) | 1.40236326 |
| 173 | Hypocalcemia (HP:0002901) | 1.39964664 |
| 174 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.38907873 |
| 175 | Steatorrhea (HP:0002570) | 1.38727342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK1 | 6.97635567 |
| 2 | MAP3K10 | 5.28192774 |
| 3 | GRK7 | 4.29029591 |
| 4 | PNCK | 3.40546877 |
| 5 | PLK4 | 2.87351255 |
| 6 | MATK | 2.75491937 |
| 7 | GRK5 | 2.73390758 |
| 8 | TGFBR1 | 2.58241352 |
| 9 | NTRK3 | 2.53747779 |
| 10 | UHMK1 | 2.51131551 |
| 11 | ICK | 2.48816773 |
| 12 | CSNK1G3 | 2.46386273 |
| 13 | TLK1 | 2.20644096 |
| 14 | BMPR1B | 2.19265150 |
| 15 | ZAK | 1.99369302 |
| 16 | CSNK1G2 | 1.91717931 |
| 17 | DAPK2 | 1.87722611 |
| 18 | MAP3K4 | 1.76043984 |
| 19 | CSNK1G1 | 1.72212525 |
| 20 | ADRBK1 | 1.71161879 |
| 21 | MAP2K1 | 1.69195247 |
| 22 | FLT3 | 1.67117397 |
| 23 | PTK2 | 1.60926198 |
| 24 | BRD4 | 1.60760966 |
| 25 | MKNK1 | 1.60085756 |
| 26 | MINK1 | 1.57864571 |
| 27 | NME1 | 1.56330078 |
| 28 | LIMK1 | 1.55932136 |
| 29 | PDGFRA | 1.55887293 |
| 30 | MARK1 | 1.53561599 |
| 31 | DYRK1B | 1.52281567 |
| 32 | BUB1 | 1.51255073 |
| 33 | MAPKAPK5 | 1.47575947 |
| 34 | TYRO3 | 1.46880365 |
| 35 | CDC7 | 1.42172675 |
| 36 | EPHB2 | 1.31103309 |
| 37 | TRIB3 | 1.22366879 |
| 38 | SCYL2 | 1.19435605 |
| 39 | DYRK2 | 1.17867757 |
| 40 | FGFR2 | 1.17616550 |
| 41 | PBK | 1.14551393 |
| 42 | RET | 1.09600031 |
| 43 | CDK12 | 1.08798015 |
| 44 | CAMK1 | 1.08712886 |
| 45 | CSNK1A1L | 1.08226301 |
| 46 | EEF2K | 1.06234860 |
| 47 | PAK6 | 1.03584493 |
| 48 | MET | 1.02814818 |
| 49 | NTRK2 | 1.02661845 |
| 50 | MAPK13 | 1.01597009 |
| 51 | CDK19 | 0.99618666 |
| 52 | KSR2 | 0.98678714 |
| 53 | RIPK1 | 0.98166256 |
| 54 | MAP3K9 | 0.97621290 |
| 55 | CAMK4 | 0.94729155 |
| 56 | CAMK1G | 0.94669143 |
| 57 | RPS6KA2 | 0.94520368 |
| 58 | PKN1 | 0.93066182 |
| 59 | EIF2AK2 | 0.92213108 |
| 60 | ADRBK2 | 0.91759882 |
| 61 | IRAK2 | 0.90660922 |
| 62 | ERBB2 | 0.90102979 |
| 63 | SRPK1 | 0.88683432 |
| 64 | MTOR | 0.88464369 |
| 65 | PLK2 | 0.88193605 |
| 66 | SGK223 | 0.83732265 |
| 67 | SGK494 | 0.83732265 |
| 68 | CAMKK1 | 0.83440754 |
| 69 | DDR2 | 0.83199453 |
| 70 | CHEK2 | 0.82411493 |
| 71 | CDK4 | 0.82168599 |
| 72 | MAP3K2 | 0.81271861 |
| 73 | CSNK1E | 0.80896070 |
| 74 | ATR | 0.78900758 |
| 75 | TSSK6 | 0.78263138 |
| 76 | CAMK1D | 0.75959828 |
| 77 | CDK14 | 0.73483392 |
| 78 | CDK15 | 0.73358511 |
| 79 | ALK | 0.73084380 |
| 80 | STK24 | 0.71813389 |
| 81 | LATS2 | 0.71262878 |
| 82 | CDK11A | 0.70328157 |
| 83 | PAK3 | 0.70031205 |
| 84 | SGK2 | 0.70029637 |
| 85 | CDK18 | 0.69982640 |
| 86 | MAP2K7 | 0.67386862 |
| 87 | INSRR | 0.66559423 |
| 88 | KSR1 | 0.65870886 |
| 89 | PHKG1 | 0.65427052 |
| 90 | PHKG2 | 0.65427052 |
| 91 | RPS6KL1 | 0.62106838 |
| 92 | RPS6KC1 | 0.62106838 |
| 93 | ERBB3 | 0.60879948 |
| 94 | PDGFRB | 0.60746433 |
| 95 | GSK3A | 0.60369631 |
| 96 | CDK5 | 0.60304704 |
| 97 | PRKAA1 | 0.60123359 |
| 98 | AURKA | 0.59573460 |
| 99 | PRKCG | 0.59399084 |
| 100 | WEE1 | 0.59269337 |
| 101 | SIK2 | 0.58320186 |
| 102 | AKT3 | 0.58284112 |
| 103 | DAPK3 | 0.57235278 |
| 104 | MAPK4 | 0.55635826 |
| 105 | CASK | 0.55412043 |
| 106 | CDK2 | 0.55162183 |
| 107 | IRAK1 | 0.54032900 |
| 108 | FGR | 0.53273518 |
| 109 | MAP2K2 | 0.51096683 |
| 110 | STK11 | 0.50170233 |
| 111 | IGF1R | 0.50133052 |
| 112 | VRK1 | 0.49336742 |
| 113 | TESK1 | 0.47247570 |
| 114 | CDK8 | 0.46890652 |
| 115 | MAP2K4 | 0.46736220 |
| 116 | PRKCE | 0.46560591 |
| 117 | CDK6 | 0.46458766 |
| 118 | DAPK1 | 0.46058784 |
| 119 | CAMK2G | 0.45873878 |
| 120 | MAPK11 | 0.45806717 |
| 121 | PRKCZ | 0.45664939 |
| 122 | MKNK2 | 0.45633269 |
| 123 | CAMK2B | 0.44738721 |
| 124 | MAPK8 | 0.44513757 |
| 125 | AKT1 | 0.44241297 |
| 126 | PRKACA | 0.43897983 |
| 127 | MAPK9 | 0.43461156 |
| 128 | CDK3 | 0.42578038 |
| 129 | DYRK3 | 0.42384940 |
| 130 | ATM | 0.41852980 |
| 131 | SIK1 | 0.40660571 |
| 132 | FGFR1 | 0.40484966 |
| 133 | PASK | 0.39834821 |
| 134 | GRK6 | 0.39384776 |
| 135 | PRKCB | 0.39126578 |
| 136 | CDK1 | 0.38881478 |
| 137 | RPS6KA6 | 0.38834159 |
| 138 | CHEK1 | 0.38320982 |
| 139 | NME2 | 0.37699818 |
| 140 | DYRK1A | 0.37475423 |
| 141 | FGFR4 | 0.37118455 |
| 142 | CAMK2A | 0.35977408 |
| 143 | MARK2 | 0.34981783 |
| 144 | ZAP70 | 0.33464542 |
| 145 | SRC | 0.32678690 |
| 146 | LMTK2 | 0.31998169 |
| 147 | ILK | 0.30674802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Tyrosine metabolism_Homo sapiens_hsa00350 | 4.32328413 |
| 2 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 4.14281687 |
| 3 | Cocaine addiction_Homo sapiens_hsa05030 | 3.28953354 |
| 4 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.72584114 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.69401910 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.67593097 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.41804080 |
| 8 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.39769846 |
| 9 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.32664948 |
| 10 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.28381682 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.24958961 |
| 12 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.12195843 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.08878186 |
| 14 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.06222322 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 2.03909591 |
| 16 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.02473025 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.95293838 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.94798057 |
| 19 | DNA replication_Homo sapiens_hsa03030 | 1.92133785 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.85553876 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.85376379 |
| 22 | Spliceosome_Homo sapiens_hsa03040 | 1.84705483 |
| 23 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.74861173 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.74806092 |
| 25 | RNA polymerase_Homo sapiens_hsa03020 | 1.74472626 |
| 26 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.73889760 |
| 27 | Circadian entrainment_Homo sapiens_hsa04713 | 1.68953242 |
| 28 | Cell cycle_Homo sapiens_hsa04110 | 1.63744651 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.61927908 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.55604649 |
| 31 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.52525821 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.50218459 |
| 33 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.49732513 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.48577289 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.46091584 |
| 36 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.44318417 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.42955380 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.42834949 |
| 39 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.36142914 |
| 40 | Colorectal cancer_Homo sapiens_hsa05210 | 1.34249910 |
| 41 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.33209214 |
| 42 | Proteasome_Homo sapiens_hsa03050 | 1.30377436 |
| 43 | Insulin secretion_Homo sapiens_hsa04911 | 1.29341383 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28909817 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26716320 |
| 46 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.26364082 |
| 47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.26182126 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26099313 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22763609 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 1.22556106 |
| 51 | RNA transport_Homo sapiens_hsa03013 | 1.22270784 |
| 52 | Thyroid cancer_Homo sapiens_hsa05216 | 1.19292976 |
| 53 | Alcoholism_Homo sapiens_hsa05034 | 1.18357251 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.17352183 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 1.12228405 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10154094 |
| 57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.09520517 |
| 58 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.09303094 |
| 59 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.06747882 |
| 60 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.01918111 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.01700280 |
| 62 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.99975443 |
| 63 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.96714250 |
| 64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95729543 |
| 65 | Melanogenesis_Homo sapiens_hsa04916 | 0.95155518 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94947705 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94668179 |
| 68 | Long-term potentiation_Homo sapiens_hsa04720 | 0.94157488 |
| 69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.92950209 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.92680150 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90192840 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88944999 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87907703 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87697529 |
| 75 | Prostate cancer_Homo sapiens_hsa05215 | 0.87428488 |
| 76 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.86996000 |
| 77 | Mismatch repair_Homo sapiens_hsa03430 | 0.86964746 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.86335759 |
| 79 | Melanoma_Homo sapiens_hsa05218 | 0.85308563 |
| 80 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.84667632 |
| 81 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.84229804 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83794059 |
| 83 | Base excision repair_Homo sapiens_hsa03410 | 0.83414625 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79409107 |
| 85 | Axon guidance_Homo sapiens_hsa04360 | 0.77419252 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75523084 |
| 87 | Taste transduction_Homo sapiens_hsa04742 | 0.75339875 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73973414 |
| 89 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73966407 |
| 90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.72055154 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69446513 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67560875 |
| 93 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67522218 |
| 94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.67305433 |
| 95 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.66641146 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66300388 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.65532765 |
| 98 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.65515715 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64891947 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64596048 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63070268 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62697351 |
| 103 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.60083766 |
| 104 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.59319810 |
| 105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58068539 |
| 106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57930086 |
| 107 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.57755587 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56872771 |
| 109 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56234318 |
| 110 | Morphine addiction_Homo sapiens_hsa05032 | 0.54833004 |
| 111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54418384 |
| 112 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.52660555 |
| 113 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50511958 |
| 114 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50437092 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49247653 |
| 116 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47572630 |
| 117 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47518881 |
| 118 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47023624 |
| 119 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46818718 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46121637 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45441392 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44406074 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43597842 |
| 124 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43298366 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42647738 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | 0.42248100 |
| 127 | Platelet activation_Homo sapiens_hsa04611 | 0.42207661 |
| 128 | Glioma_Homo sapiens_hsa05214 | 0.39433348 |
| 129 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39216989 |
| 130 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34684214 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.34206595 |
| 132 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31423458 |
| 133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29284590 |
| 134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27083635 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26235973 |
| 136 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.26022693 |
| 137 | GABAergic synapse_Homo sapiens_hsa04727 | 0.25341221 |
| 138 | Nicotine addiction_Homo sapiens_hsa05033 | 0.25272751 |
| 139 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.25176638 |
| 140 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23426788 |
| 141 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.19743572 |
| 142 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.18288102 |
| 143 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.16774947 |
| 144 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.16337599 |
| 145 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.15872298 |
| 146 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.14754118 |

